Viewing Study NCT05638451


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:43 PM
Study NCT ID: NCT05638451
Status: UNKNOWN
Last Update Posted: 2024-06-05
First Post: 2022-11-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Sponsor: Zhujiang Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module